Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...
On this "Face the Nation with Margaret Brennan" broadcast, National Security Adviser Mike Waltz and Rep. Rand Paul join ...
The Washington Post on MSN13d
How the Justice Department is remaking itself in Trump’s imageAttorney General Pam Bondi has curtailed Justice Department anti-corruption efforts, ratcheted up immigration enforcement and ...
“I was asked to provide cover for a decision that had already ... open investigations into at least 19 companies, including at Pfizer’s operations in China and Mexico and a Toyota subsidiary ...
Life coaching requires no mental health education, and it sometimes attracts former therapists who have lost their license to practice, reports ProPublica. Other states making news are New York, Iowa, ...
6don MSN
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Many companies now don’t require candidates to submit cover letters. But should you still submit them? The author argues that ...
The rapid advancement of generative AI (GenAI) is fundamentally reshaping the modern workplace, driving a wave of new ...
Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine. Siding with Moderna, an American pharmaceutical ...
March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback